The role of oncogenes and tumor suppressor genes in determining survival rates of lung cancer patients in the population of North Sumatra, Indonesia
F1000Research · 2023
DOI: 10.12688/f1000research.113303.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift F1000Research, 2023. Verfasst von Noni Novisari Soeroso und 3 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Oncology Division, Department of Pulmonology and Respiratory Medicine, Universitas Sumatera Utara, Medan, Sumatera Utara, 20155, Indonesia. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Gaining a better understanding of molecular alterations in the pathogenesis of lung cancer reveals a significant change in approach to the management and prognosis of lung cancer. Several oncogenes and tumor suppressor genes have been identified and have different roles related to survival rates in lung cancer patients. This study aims to determine the role of KRAS, EGFR, and TP53 mutations in the survival rate of lung cancer patients in the population of North Sumatra.
Methods
This is a retrospective cohort study involving 108 subjects diagnosed with lung cancer from histopathology specimens. DNA extractions were performed using FFPE followed by PCR examinations for assessing the expressions of EGFR, RAS, and TP53 protein. Sequencing analysis was carried out to determine the mutations of EGFR exon 19 and 21, RAS protein exon 2, and TP53 exon 5-6 and 8-9. Data input and analysis were conducted using statistical analysis software for Windows. The survival rate analysis was presented with Kaplan Meier.
Results
52 subjects completed all procedures in this study. Most of the subjects are male (75%), above 60 years old (53.8%), heavy smokers (75%), and suffer from adenocarcinoma type of lung cancer (69.2%). No subjects showed KRAS exon 2 mutations. Overall survival rates increased in patients with EGFR mutations (15 months compared to 8 months; p =0.001) and decreased in patients with TP53 mutations (7 months compared to 9 months; p =0.148). Also, there was increasing Progression-Free Survival in patients with EGFR mutations (6 months compared to 3 months) ( p =0.19) and decreasing PFS in patients with TP53 mutations (3 months compared to 6 months) ( p =0.07).
Conclusions
There were no KRAS mutations in this study. EGFR mutations showed a higher survival rate, while TP53 mutations showed a lower survival rate in overall survival and progression-free survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Thoracic Oncology Division, Department of Pulmonology and Respiratory Medicine, Universitas Sumatera Utara, Medan, Sumatera Utara, 20155, Indonesia.
- Department of Pulmonology and Respiratory Medicine, Universitas Sumatera Utara, Medan, Sumatera Utara, 20155, Indonesia.
- Faculty of Medicine, Universitas Sumatera Utara, Medan, Sumatera Utara, 20155, Indonesia.
- Department of Statistics, Universitas Sumatera Utara, Medan, Sumatera Utara, 20155, Indonesia.
ORCID-Profile: Johan Samuel Sitanggang
Zitieren
APA
Soeroso, N. N., Ananda, F. R., Sitanggang, J. S., & Vinolina, N. S. (2023). The role of oncogenes and tumor suppressor genes in determining survival rates of lung cancer patients in the population of North Sumatra, Indonesia. F1000Research. https://doi.org/10.12688/f1000research.113303.2
Vancouver
Soeroso NN, Ananda FR, Sitanggang JS, Vinolina NS. The role of oncogenes and tumor suppressor genes in determining survival rates of lung cancer patients in the population of North Sumatra, Indonesia. F1000Research. 2023. doi:10.12688/f1000research.113303.2
BibTeX
@article{Soeroso2023,
author = {Soeroso, Noni Novisari and Ananda, Fannie Rizki and Sitanggang, Johan Samuel and Vinolina, Noverita Sprinse},
title = {The role of oncogenes and tumor suppressor genes in determining survival rates of lung cancer patients in the population of North Sumatra, Indonesia},
journal = {F1000Research},
year = {2023},
doi = {10.12688/f1000research.113303.2}
}
EUVIMED